Literature DB >> 23512376

Functional evaluation of the joints in acromegalic patients and associated factors.

Leandro Lemgruber Kropf1, Miguel Madeira, Leonardo Vieira Neto, Mônica Roberto Gadelha, Maria Lucia Fleiuss de Farias.   

Abstract

This study aims to evaluate the presence of arthropathy in the large peripheral joints most commonly affected in acromegaly and to classify the severity according to the functional assessment of each joint to identify any factor that could predict the development of arthropathy and its level of severity. Seventy-one acromegalic patients were interviewed and underwent a physical examination of the knees, hips, and shoulders to identify the presence of arthropathy. The disease was functionally classified as more severe or less severe, according to a specific functional scale. We studied 21 males (29.5%) and 50 females (70.5%) with a mean age of 49.5 ± 14.5 years. Arthropathy in the studied joints was observed in 40 patients (prevalence of 56%), and a statistically significant association with the presence of arthropathy was observed for three of the evaluated factors: increased body mass index (BMI), older age at diagnosis of acromegaly, and female gender. There was no association with disease control or other factors related to acromegaly. We classified 19 patients as having more functionally severe arthropathy and identified two factors associated with its development: increased BMI and lower levels of insulin-like growth factor type I. The relationship of factors such as female sex and BMI, which are also related to osteoarthritis, with arthropathy in acromegalic patients suggested a high prevalence of irreversible joint disease present at diagnosis of acromegaly. We highlight the BMI, which was associated with either the presence of arthropathy or more severe arthropathy, which demonstrates the importance of body weight control in the management of acromegalic patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512376     DOI: 10.1007/s10067-013-2219-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

Review 1.  Neurosurgical implications of Carney complex.

Authors:  J C Watson; C A Stratakis; P K Bryant-Greenwood; C A Koch; L S Kirschner; T Nguyen; J A Carney; E H Oldfield
Journal:  J Neurosurg       Date:  2000-03       Impact factor: 5.115

Review 2.  Acromegalic arthropathy and sleep apnea.

Authors:  A Barkan
Journal:  J Endocrinol       Date:  1997-10       Impact factor: 4.286

3.  Acromegalic arthropathy.

Authors:  R Bluestone; E G Bywaters; M Hartog; P J Holt; S Hyde
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

4.  Peripheral joint manifestations of acromegaly.

Authors:  L C Detenbeck; H A Tressler; J D O'Duffy; R V Randall
Journal:  Clin Orthop Relat Res       Date:  1973 Mar-Apr       Impact factor: 4.176

5.  [Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and results for treatment of prolactin and growth hormone secreting pituitary tumors].

Authors:  Tobias D Wiesner; Christos Trantakis; Jürgen Meixensberger; Christian A Koch; Claus Zimmer; Ralf Paschke
Journal:  Med Klin (Munich)       Date:  2005-04-15

6.  Treatment of chronic rotator-cuff impingement by arthroscopic subacromial decompression.

Authors:  R W Nutton; J M McBirnie; C Phillips
Journal:  J Bone Joint Surg Br       Date:  1997-01

7.  Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study.

Authors:  R F Dons; P Rosselet; B Pastakia; J Doppman; P Gorden
Journal:  Clin Endocrinol (Oxf)       Date:  1988-05       Impact factor: 3.478

8.  Reversibility of joint thickening in acromegalic patients: an ultrasonography study.

Authors:  A Colao; P Marzullo; G Vallone; V Marinò; M Annecchino; D Ferone; D De Brasi; R Scarpa; P Oriente; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

9.  Acromegalic axial arthropathy: a clinical case-control study.

Authors:  Raffaele Scarpa; Davide De Brasi; Rosario Pivonello; Paolo Marzullo; Francesco Manguso; Antonio Sodano; Pasquale Oriente; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

10.  Articular manifestations of acromegaly.

Authors:  M Podgorski; B Robinson; A Weissberger; J Stiel; S Wang; P M Brooks
Journal:  Aust N Z J Med       Date:  1988-02
View more
  11 in total

1.  What the mind knows but the eyes may still miss: reducing the 'Acromegalic Window'.

Authors:  Parijat De; Danielle R G Foucault
Journal:  BMJ Case Rep       Date:  2014-05-26

2.  Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.

Authors:  L M Fatti; B Cangiano; G Vitale; L Persani; G Mantovani; E Sala; M Arosio; P Maffei; F Dassie; M Mormando; A Giampietro; L Tanda; E R Masiello; E Nazzari; D Ferone; S Corbetta; E Passeri; F Guaraldi; S Grottoli; S Cannavò; M L T Torre; D Soranna; A Zambon; F Cavagnini; M Scacchi
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

Review 3.  Acromegaly: clinical features at diagnosis.

Authors:  Lucio Vilar; Clarice Freitas Vilar; Ruy Lyra; Raissa Lyra; Luciana A Naves
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 4.  Musculoskeletal Effects of Altered GH Action.

Authors:  Jonathan A Young; Shouan Zhu; Edward O List; Silvana Duran-Ortiz; Yosri Slama; Darlene E Berryman
Journal:  Front Physiol       Date:  2022-05-19       Impact factor: 4.755

Review 5.  Acromegaly in the elderly patients.

Authors:  Maria Rosaria Ambrosio; Irene Gagliardi; Sabrina Chiloiro; Ana Gonçalves Ferreira; Marta Bondanelli; Antonella Giampietro; Antonio Bianchi; Laura De Marinis; Maria Fleseriu; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

Review 6.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

7.  Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study.

Authors:  A Colao; L F S Grasso; M Di Cera; P Thompson-Leduc; W Y Cheng; H C Cheung; M S Duh; M P Neary; A M Pedroncelli; R Maamari; R Pivonello
Journal:  J Endocrinol Invest       Date:  2019-11-18       Impact factor: 5.467

8.  Prevalence of Comorbidities among Patients with Acromegaly.

Authors:  Sajjad Ali Khan; Nanik Ram; Muhammad Qamar Masood; Najmul Islam
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

9.  The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment.

Authors:  Naoki Yamamoto; Shin Urai; Hidenori Fukuoka; Masaaki Yamamoto; Kenichi Yoshida; Masaki Suzuki; Hiroki Shichi; Yasunori Fujita; Keitaro Kanie; Genzo Iguchi; Yutaka Takahashi; Wataru Ogawa
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-03       Impact factor: 5.555

10.  Prevalence of comorbidities and associated factors in acromegaly patients in the Turkish population

Authors:  Mustafa Can; Muhammet Kocabaş; İlker Çordan; Hatice Çalışkan Burgucu; Melia Karaköse; Mustafa Kulaksızoğlu; Feridun Karakurt
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.